Extended Data Table 1. Baseline characteristics for patients recruited to targeted treatment arms in NLMT (all patients registered up to 30 November 2019).
| All (n=302) | |
|---|---|
| Age (years) | |
| Median | 65 |
| Inter-quartile range | 59-70 |
| Range | 26-86 |
| Performance Status | |
| 0 | 64 (21%) |
| 1 | 203 (67%) |
| 2 | 32 (11%) |
| Not known | 3(1%) |
| Histology | |
| Adenocarcinoma | 212 (70%) |
| Squamous cell carcinoma | 72 (24%) |
| Carcinoma NOS | 9 (3%) |
| Not known | 9 (3%) |
| Smoking History (pack years) | |
| Never-smoker | 40 (13%) |
| <10 | 46 (15%) |
| 10-30 | 67 (22%) |
| >30 | 100 (33%) |
| Not known | 49 (16%) |
| Metastases | |
| No | 100 (33%) |
| Yes | 197 (65%) |
| Not known | 5 (2%) |
| Previous lines (systemic anticancer treatment) | |
| One | 96 (32%) |
| Two | 104 (34%) |
| Three | 47 (16%) |
| More than three | 35 (12%) |
| Not known | 20 (7%) |